ADC Therapeutics SA (ADCT) Tops Q1 EPS by 7c

ADC Therapeutics SA (NYSE: ADCT) reported Q1 EPS of ($0.13), $0.07 better than the analyst estimate of ($0.20). Revenue for the quarter came in at $20.85 million versus the consensus estimate of $20.04 million.

For earnings history and earnings-related data on ADC Therapeutics SA (ADCT) click here.

You May Also Be Interested In

• RXO shares soar as C.H. Robinson announces $5.8B cash and stock buyout
• Amgen (AMGN) Reiterated at Neutral by Cantor Fitzgerald - Returns to Being a Consensus Long
• Atlas Energy Solutions Inc (AESI) PT Lowered to $20 at Stephens